Literature DB >> 15321784

Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs.

Eleonora Cavarra1, Fabio Carraro, Silvia Fineschi, Antonella Naldini, Barbara Bartalesi, Annalisa Pucci, Giuseppe Lungarella.   

Abstract

The sensitivity to the fibrosis-inducing effect of bleomycin varies considerably from species to species, the reasons for which are unknown. The variability of the response in different strains of mice is well documented. Recent evidence indicates that the upregulated expression of cytokines and cytokine receptors may be involved. We evaluated the expression pattern of some cytokines and their receptors in C57Bl/6J bleomycin-sensitive and Balb/C bleomycin-resistant mice. Animals from both strains received, under ether anesthesia, either saline (50 microl) or bleomycin (0.1 U/50 microl) intratracheally. At various times after the treatment, the lungs were analyzed for cytokines and cytokine receptors by histochemistry and their mRNA by RNase protection assay. A significantly increased expression of TNF-alpha and IL-1beta was observed in both strains. However, an upregulated lung expression for TNF-alpha and IL-1 receptors was observed in C57Bl/6J-sensitive animals only. This profile is evident from 63 h onward. In addition to TNF-alpha, bleomycin administration also resulted in the upregulated expression of TGF-beta in the lungs of both strains at 8 h and in an enhanced expression of TGF-beta receptors I and II in C57Bl/6J mice only. The upregulation of TGF-beta receptor expression was preceded in this strain by an increased expression of IL-4, IL-13, and IL-13 receptor-alpha (at 8 h after bleomycin) and followed by an upregulation of gp130 and IL-6. The difference we observed in the cytokine receptor profile may offer an additional explanation for the different fibrogenic response of the two mouse strains to bleomycin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321784     DOI: 10.1152/ajplung.00170.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  20 in total

1.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

Review 2.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

3.  Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis.

Authors:  Lisa R Young; Rajamouli Pasula; Peter M Gulleman; Gail H Deutsch; Francis X McCormack
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-15       Impact factor: 6.914

4.  Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis.

Authors:  N P Barlo; C H M van Moorsel; N M Korthagen; M Heron; G T Rijkers; H J T Ruven; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 5.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

6.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

8.  Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts.

Authors:  L Gallelli; D Falcone; G Pelaia; T Renda; R Terracciano; N Malara; A Vatrella; A Sanduzzi; B D'Agostino; F Rossi; C Vancheri; R Maselli; S A Marsico; R Savino
Journal:  Cell Prolif       Date:  2008-04-24       Impact factor: 6.831

9.  Role of NOS2 in pulmonary injury and repair in response to bleomycin.

Authors:  Changjiang Guo; Elena Atochina-Vasserman; Helen Abramova; Blessy George; Veleeparambil Manoj; Pamela Scott; Andrew Gow
Journal:  Free Radic Biol Med       Date:  2015-10-23       Impact factor: 7.376

10.  Peripheral-to-central immune communication at the area postrema glial-barrier following bleomycin-induced sterile lung injury in adult rats.

Authors:  David G Litvin; Scott J Denstaedt; Lauren F Borkowski; Nicole L Nichols; Thomas E Dick; Corey B Smith; Frank J Jacono
Journal:  Brain Behav Immun       Date:  2020-02-22       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.